Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
by
Arca, Marcello
, Blom, Dirk J
, Williams, Karren R
, Geary, Richard S
, Soran, Handrean
, Freedman, Steven D
, Alexander, Veronica J
, Civeira, Fernando
, Digenio, Andres
, Tsimikas, Sotirios
, O’Dea, Louis
, Gaudet, Daniel
, Hughes, Steven G
, Hemphill, Linda
, Witztum, Joseph L
, Stroes, Erik S.G
, Bruckert, Eric
, Bergeron, Jean
, Yang, Qingqing
in
Adult
/ Aged
/ Analysis of Variance
/ Antisense therapy
/ Apolipoprotein C-III
/ Apolipoprotein C-III - antagonists & inhibitors
/ Apolipoprotein C-III - blood
/ Apolipoprotein C-III - genetics
/ Apolipoproteins
/ Clinical trials
/ Double-Blind Method
/ Drug dosages
/ Fasting
/ Fatty acids
/ Female
/ Genetic disorders
/ Humans
/ Hyperlipoproteinemia Type I - blood
/ Hyperlipoproteinemia Type I - drug therapy
/ Injection
/ Injections, Subcutaneous - adverse effects
/ Laboratories
/ Life Sciences
/ Lipase
/ Lipoprotein lipase
/ Lipoproteins
/ Male
/ Middle Aged
/ mRNA
/ Mutation
/ Oligonucleotides - administration & dosage
/ Oligonucleotides - adverse effects
/ Oligonucleotides - therapeutic use
/ Pancreatitis
/ Pharmaceuticals
/ Platelet Count
/ Platelets
/ RNA, Messenger - antagonists & inhibitors
/ Statistical analysis
/ Thrombocytopenia
/ Thrombocytopenia - chemically induced
/ Triglycerides - blood
/ Young Adult
2019
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
by
Arca, Marcello
, Blom, Dirk J
, Williams, Karren R
, Geary, Richard S
, Soran, Handrean
, Freedman, Steven D
, Alexander, Veronica J
, Civeira, Fernando
, Digenio, Andres
, Tsimikas, Sotirios
, O’Dea, Louis
, Gaudet, Daniel
, Hughes, Steven G
, Hemphill, Linda
, Witztum, Joseph L
, Stroes, Erik S.G
, Bruckert, Eric
, Bergeron, Jean
, Yang, Qingqing
in
Adult
/ Aged
/ Analysis of Variance
/ Antisense therapy
/ Apolipoprotein C-III
/ Apolipoprotein C-III - antagonists & inhibitors
/ Apolipoprotein C-III - blood
/ Apolipoprotein C-III - genetics
/ Apolipoproteins
/ Clinical trials
/ Double-Blind Method
/ Drug dosages
/ Fasting
/ Fatty acids
/ Female
/ Genetic disorders
/ Humans
/ Hyperlipoproteinemia Type I - blood
/ Hyperlipoproteinemia Type I - drug therapy
/ Injection
/ Injections, Subcutaneous - adverse effects
/ Laboratories
/ Life Sciences
/ Lipase
/ Lipoprotein lipase
/ Lipoproteins
/ Male
/ Middle Aged
/ mRNA
/ Mutation
/ Oligonucleotides - administration & dosage
/ Oligonucleotides - adverse effects
/ Oligonucleotides - therapeutic use
/ Pancreatitis
/ Pharmaceuticals
/ Platelet Count
/ Platelets
/ RNA, Messenger - antagonists & inhibitors
/ Statistical analysis
/ Thrombocytopenia
/ Thrombocytopenia - chemically induced
/ Triglycerides - blood
/ Young Adult
2019
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
by
Arca, Marcello
, Blom, Dirk J
, Williams, Karren R
, Geary, Richard S
, Soran, Handrean
, Freedman, Steven D
, Alexander, Veronica J
, Civeira, Fernando
, Digenio, Andres
, Tsimikas, Sotirios
, O’Dea, Louis
, Gaudet, Daniel
, Hughes, Steven G
, Hemphill, Linda
, Witztum, Joseph L
, Stroes, Erik S.G
, Bruckert, Eric
, Bergeron, Jean
, Yang, Qingqing
in
Adult
/ Aged
/ Analysis of Variance
/ Antisense therapy
/ Apolipoprotein C-III
/ Apolipoprotein C-III - antagonists & inhibitors
/ Apolipoprotein C-III - blood
/ Apolipoprotein C-III - genetics
/ Apolipoproteins
/ Clinical trials
/ Double-Blind Method
/ Drug dosages
/ Fasting
/ Fatty acids
/ Female
/ Genetic disorders
/ Humans
/ Hyperlipoproteinemia Type I - blood
/ Hyperlipoproteinemia Type I - drug therapy
/ Injection
/ Injections, Subcutaneous - adverse effects
/ Laboratories
/ Life Sciences
/ Lipase
/ Lipoprotein lipase
/ Lipoproteins
/ Male
/ Middle Aged
/ mRNA
/ Mutation
/ Oligonucleotides - administration & dosage
/ Oligonucleotides - adverse effects
/ Oligonucleotides - therapeutic use
/ Pancreatitis
/ Pharmaceuticals
/ Platelet Count
/ Platelets
/ RNA, Messenger - antagonists & inhibitors
/ Statistical analysis
/ Thrombocytopenia
/ Thrombocytopenia - chemically induced
/ Triglycerides - blood
/ Young Adult
2019
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
Journal Article
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
2019
Request Book From Autostore
and Choose the Collection Method
Overview
This phase 3 trial showed that treatment with volanesorsen, an antisense oligonucleotide drug complementary to mRNA encoding apolipoprotein C-III, resulted in a mean reduction in triglyceride levels of 77% over the course of 3 months.
Publisher
Massachusetts Medical Society
Subject
/ Aged
/ Apolipoprotein C-III - antagonists & inhibitors
/ Apolipoprotein C-III - blood
/ Apolipoprotein C-III - genetics
/ Fasting
/ Female
/ Humans
/ Hyperlipoproteinemia Type I - blood
/ Hyperlipoproteinemia Type I - drug therapy
/ Injections, Subcutaneous - adverse effects
/ Lipase
/ Male
/ mRNA
/ Mutation
/ Oligonucleotides - administration & dosage
/ Oligonucleotides - adverse effects
/ Oligonucleotides - therapeutic use
/ RNA, Messenger - antagonists & inhibitors
This website uses cookies to ensure you get the best experience on our website.